These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 12067634)
1. Parkinson's disease: one biochemical pathway to fit all genes? Krüger R; Eberhardt O; Riess O; Schulz JB Trends Mol Med; 2002 May; 8(5):236-40. PubMed ID: 12067634 [TBL] [Abstract][Full Text] [Related]
2. Genetics of Parkinson's disease. Gasser T J Neurol; 2001 Oct; 248(10):833-40. PubMed ID: 11697518 [TBL] [Abstract][Full Text] [Related]
3. Genetics of Parkinson's disease and biochemical studies of implicated gene products. Lansbury PT; Brice A Curr Opin Cell Biol; 2002 Oct; 14(5):653-60. PubMed ID: 12231362 [TBL] [Abstract][Full Text] [Related]
4. Importance of familial Parkinson's disease and parkinsonism to the understanding of nigral degeneration in sporadic Parkinson's disease. Hattori N; Shimura H; Kubo S; Wang M; Shimizu N; Tanaka K; Mizuno Y J Neural Transm Suppl; 2000; (60):101-16. PubMed ID: 11205133 [TBL] [Abstract][Full Text] [Related]
5. Genetics of Parkinson's disease. Polymeropoulos MH Ann N Y Acad Sci; 2000; 920():28-32. PubMed ID: 11193165 [TBL] [Abstract][Full Text] [Related]
6. Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson's disease. McNaught KS; Olanow CW Ann Neurol; 2003; 53 Suppl 3():S73-84; discussion S84-6. PubMed ID: 12666100 [TBL] [Abstract][Full Text] [Related]
7. Complex interactions in Parkinson's disease: a two-phased approach. Maraganore DM; de Andrade M; Lesnick TG; Farrer MJ; Bower JH; Hardy JA; Rocca WA Mov Disord; 2003 Jun; 18(6):631-6. PubMed ID: 12784265 [TBL] [Abstract][Full Text] [Related]
8. Genetics of Parkinson's disease and biochemical studies of implicated gene products. Lansbury PT; Brice A Curr Opin Genet Dev; 2002 Jun; 12(3):299-306. PubMed ID: 12076673 [TBL] [Abstract][Full Text] [Related]
9. [Parkinson's disease: what have we learned from the genes responsible for familial forms?]. Corti O; Brice A Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396 [TBL] [Abstract][Full Text] [Related]
10. The cast of molecular characters in Parkinson's disease: felons, conspirators, and suspects. Lim KL; Dawson VL; Dawson TM Ann N Y Acad Sci; 2003 Jun; 991():80-92. PubMed ID: 12846976 [TBL] [Abstract][Full Text] [Related]
11. Recent advances in the genetics and pathogenesis of Parkinson disease. Mouradian MM Neurology; 2002 Jan; 58(2):179-85. PubMed ID: 11805242 [TBL] [Abstract][Full Text] [Related]
12. [Parkin, alpha-synuclein and other molecular aspects of Parkinson's disease]. Corti O; Brice A J Soc Biol; 2002; 196(1):95-10. PubMed ID: 12134640 [TBL] [Abstract][Full Text] [Related]
13. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533 [TBL] [Abstract][Full Text] [Related]
14. Expression of alpha-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: genes associated with familial Parkinson's disease. Solano SM; Miller DW; Augood SJ; Young AB; Penney JB Ann Neurol; 2000 Feb; 47(2):201-10. PubMed ID: 10665491 [TBL] [Abstract][Full Text] [Related]